DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens. The company is named after its core technology, DIOSynVax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines), a new system that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
| Website | http://www.diosvax.com |
| Employees | 20 (14 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Information Technology |
| Keywords | Infectious Disease, Disease Prevention, Vaccine Development, Drug Discovery, Immunotherapy, Therapeutic Vaccines, Novel Therapeutics, Biotechnology, Antiviral Therapies, Pharmaceutical Research, Health Technology, Clinical Trials, Synthetic Biology, Pathogen Detection, Precision Medicine, Immuno-Oncology |
| Competitors | Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Regeneron, Moderna Therapeutics, Novavax, CureVac +39 more (view full list) |
Looking for a particular DIOSynVax employee's phone or email?
DIOSynVax Questions
Rebecca Kinsley is the CEO of DIOSynVax.
14 people are employed at DIOSynVax.
Top DIOSynVax Employees
-
Rebecca Kinsley
Chief Executive Officer at DIOSynVax
Cambridge, GB1 -
Matthew Davies
Head of Bioinformatics at DIOSynVax
Cambridge, GB33 -
2
-
David Moss
Senior Project Manager at DIOSynVax
Hitchin, GB2 -
3
-
Srivatsan Parthasarathy
Junior Scientist at DIOSynVax
Cambridge, GB1 -
Jonathan Holbrook
Immunologist at DIOSynVax
Cambridge, GB1 -
Matteo Ferrari
Business Development Associate and IP Specialist at DIOSynVax
Genzano di Roma, IT1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
